MARKET

HROW

HROW

Harrow Health Inc
NASDAQ
12.09
-0.06
-0.49%
After Hours: 12.09 0 0.00% 16:01 12/07 EST
OPEN
12.22
PREV CLOSE
12.15
HIGH
13.09
LOW
11.85
VOLUME
296.72K
TURNOVER
0
52 WEEK HIGH
13.29
52 WEEK LOW
5.40
MARKET CAP
331.43M
P/E (TTM)
-14.6085
1D
5D
1M
3M
1Y
5Y
BRIEF-Harrow And Ior Partners Expand National Product Supply Agreement
Reuters · 11/30 13:03
Harrow Health Expands Product Supply Deal With iOR Partners
Harrow Health Expands Product Supply Deal With iOR Partners
MT Newswires · 11/30 09:53
Harrow Health Third Quarter 2022 Earnings: Misses Expectations
Harrow Health ( NASDAQ:HROW ) Third Quarter 2022 Results Key Financial Results Revenue: US$22.8m (up 22% from 3Q 2021...
Simply Wall St. · 11/16 10:06
Harrow Health Q3 EPS $(0.06) Up From $(0.20) YoY, Sales $22.80M Miss $23.15M Estimate
Benzinga · 11/14 21:08
BRIEF-Melt Pharmaceuticals Announces Dosing Of Last Patient In Phase 2 Pivotal Efficacy And Safety Study For MELT-300
Reuters · 10/27 13:30
NGM Biopharmaceuticals, Fox Corporation And Some Other Big Stocks Moving Lower On Monday
U.S. stocks traded higher, with the Dow Jones gaining more than 400 points on Monday. Here are some big stocks recording losses in today’s session.
Benzinga · 10/17 15:13
Harrow Health, Inc. (NASDAQ:HROW) has caught the attention of institutional investors who hold a sizeable 48% stake
If you want to know who really controls Harrow Health, Inc. ( NASDAQ:HROW ), then you'll have to look at the makeup of...
Simply Wall St. · 10/13 13:35
BRIEF-Harrow Health Enters Into Mutual Termination Agreement With Eyepoint
BRIEF-Harrow Health Enters Into Mutual Termination Agreement With Eyepoint
Reuters · 10/11 21:34
More
About HROW
Harrow Health, Inc. is an ophthalmic-focused healthcare company. The Company's business specializes in the development, production and sale of medications that serve unmet needs in the marketplace through its subsidiaries and deconsolidated companies. The Company owns and operates ImprimisRx, an ophthalmology-focused pharmaceutical business, and Visionology, Inc. (Visionology), a direct-to-consumer eye care subsidiary focused on chronic eye disease. In addition, the Company holds non-controlling equity positions in Surface Ophthalmics, Inc. (Surface) and Melt Pharmaceuticals, Inc. (Melt). It also owns royalty rights in various drug candidates being developed by Surface and Melt.

Webull offers kinds of Harrow Health Inc stock information, including NASDAQ:HROW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HROW stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading HROW stock methods without spending real money on the virtual paper trading platform.